Antifungal and antibacterial properties of a silver-loaded cellulosic fiber

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 77, Issue 1, 2006, Pages 156-163

  Hipler, Uta Christina ^a   Elsner, Peter ^a   Fluhr, Joachim W ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antibacterial; Antimycotic; Cellulose; Silver loaded

Indexed keywords

CELLULOSE; FUNGI; PHYSIOLOGY; STRESS ANALYSIS; TEXTILES;

ANTIBACTERIAL; ANTIBACTERIAL EFFECTS; ANTIMYCOTIC; SILVER-LOADED;

NATURAL FIBERS;

CELLULOSE; SILVER;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA TROPICALIS; DIABETIC PATIENT; ESCHERICHIA COLI; FIBER; HYPERHIDROSIS; IN VITRO STUDY; INFECTION SENSITIVITY; MYCOSIS; SKIN; STAPHYLOCOCCUS AUREUS; TEXTILE;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA; CELLULOSE; ESCHERICHIA COLI; HUMANS; MATERIALS TESTING; MICROBIAL SENSITIVITY TESTS; SEAWEED; SILVER;

CELLULOSE FIBERS; PHYSIOLOGY; TEXTILES;

EID: 33645407158     PISSN: 00219304     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30413     Document Type: Article

References (47)

1. Dhabhar FS. Acute stress enhances while chronic stress supresses skin immunity: The role of stress hormones and leukocyte trafficking. Ann NY Acad Sci 2000;917:876-893.
2. Friedman EM, Lawrence DA. Environmental stress mediates changes in neuroimmunological interactions. Toxicol Sci 2002;67:4-10.
3. Fluhr JW, Behne MJ, Brown BE, Moskowitz DG, Selden C, Mao-Qiang M, Mauro TM, Elias PM, Feingold KR. Stratum corneum acidification in neonatal skin: Secretory phospholipase A2 and sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol 2004;122:320-329.
4. Hachem JP, Crumrine D, Fluhr JW, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003;121:345-353.
5. Elsner P. What textile engineers should know about the human skin. Curr Probl Dermatol 2003;31:24-34.
6. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: Missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352-363.
7. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, Voorhees JJ. Mechanisms of photoaging and chronical skin aging. Arch Dermatol 2002;138:1462-1470.
8. Bolognia JL. Aging skin. Am J Med 1995;98:99-103.
9. Fenske NA, Lober CW. Skin changes of aging: Pathological implications. Geriatrics 1990;45:27-35.
10. Zikeli S. SeaCell® Active - A new cellulosic fiber with antimicrobial properties. Presented at the Avantex-International Forum and Symposium for High-tech Apparel Textiles, Frankfurt, Germany, May 13-15, 2002.
11. Zikeli S, Wolschner B, Eichinger D, Jurkovic R, Firgo H. Process for producing solutions of cellulose. Patent EP 0356419. 1990.
12. Bauer R, Taeger E, Zikeli S. ALCERU-Manufacture of cellulosic materials by using organic solvent process. In Seminar on Cellulosic Man-made Fibers in the New Millenium, Stenungsund, Sweden, June 13-15, 2000.
13. Zikeli S, Ecker F. Method for spinning a spinning solution and spinning head. Patent WO 01/81663. 2001.
14. Zikeli S, Ecker F. Verfahren und Vorrichtung zur Herstellung von Endlosformkörpern. Patent DE 10037923. 2000.
15. Zikeli S. Lyocell fibers with health-promoting effect through incorporation of seaweed. Chem Fibers Int 2001;51:272-276.
16. Zikeli S. Lyocell Fasern mit gesundheitsfördernder Wirkung durch Inkorporation von Algen. 7. Symposium Nachwachsende Rohstoffe für die Chemie 2001;18:449-466.
17. Zikeli S, Endl T, Martl MG. Polymer compositions and moulded bodies made therefrom. Patent WO01/62844. 2001.
18. Zikeli S, Endl T, Martl MG. Cellulose sharped body and method for the production thereof. Patent WO01/62845. 2001.
19. Strasburger E, Noll F, Schenck H, Schimper AFW. Lehrbuch der Botanik für Hochschulen, 33rd ed. Stuttgart: Gustav Fischer Verlag; 1991.
20. Hoppe HA, Levering T, Tanaka Y. Marine Algae in Pharmaceutical Science. Berlin: Walter de Gruyter; 1979.
21. Gorban EN, Kuprash LP, Gorban NE. Spirulina: Perspectives of application in medicine. Lik Sprava 2003;7:100-110.
22. Kang HS, Chung HY, Kim JY, Son BW, Jung HA, Choi JS. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch Pharm Res 2004;27:194-198.
23. Linares AF, Loikkanen J, Jorge MF, Soria RB, Novoa AV. Antioxidant and neuroprotective activity of the extract from seaweed, Halimeda incrassata (Ellis) Lamouroux, against in vitro and in vivo toxicity induced by methyl-mercury. Vet Hum Toxicol 2004;46:1-5.
24. Ramazanov Z, Jimenez del Rio M, Ziegenfuss T. Sulfated polysaccharides of brown seaweed Cystoseira canariensis bind serum myostatin protein. Acta Physiol Pharmacol Bulg 2003;27:101-106.
25. Zhou D, Zhang L, Zhou J, Guo S. Cellulose/chitin beads for absorption of heavy metals in aqueous solution. Water Res 2004;38:2643-2650.
26. Pedersen A. Studies on phenol content and heavy metal uptake in fucoids. Hydrobiologia 1984;116/117:498-504.
27. Leusch A, Holan ZR, Volesky B. Biosorption of heavy metals by chemically-reinforced biomass of marine algae. J Chem Technol Biotechnol 1995;62:279-288.
28. Gaugner A, Mempel M, Schekatz A, Schäfer T, Ring J, Abeck D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003;207:15-21.
29. Mundy GR, Guise TA. Hormonal control of calcium homeostasis. Clin Chem 1999;45:1347-1352.
30. Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004;50:854-858.
31. Millard PJ, Roth BL, Thi HP, Yue ST, Haugland RP. Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeasts. Appl Environ Microbiol 1997;63:2897-2905.
32. Rodgers GL, Mortensen JE, Fisher MC, Long SS. In vitro susceptibilty testing of topical antimicrobial agents in pesiatric burn patients: Comparison of two methods. J Burn Care Rehabil 1997;18:406-410.
33. Grier N. Silver and its compounds. In: Block SS, editor. Antiseptics and Disinfectants. Philadelphia, PA: Lea and Febiger; 1977. p 375-389.
34. Muller G, Winkler Y, Kramer A. Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220. J Hosp Infect 2003;53:211-214.
35. Bosetti M, Masse A, Tobin E, Cannas M. Silver coated materials for external fixation devices: In vitro biocompatibility and genotoxicity. Biomaterials 2002;23:887-892.
36. Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther 1995;9:547-559.
37. Rosenkranz HS, Rosenkranz S. Silver sulfadiazine: Interaction with isolated desoxyribonucleic acid. Antimicrob Agents Chemother 1972;2:373-383.
38. Modak SM, Fox FL. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973;22:2391-2404.
39. Bragg PD, Rainnie DJ. The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 1974;20:883-889.
40. Lansdown AB. Silver. I: Its antibacterial properties and mechanism of action. J Wound Care 2002;11:125-130.
41. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000;26:131-138.
42. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing: J Burn Care Rehabil 1999;20:195-200.
43. Williams RL, Doherty PJ, Vince DG, Grashoff GJ, Williams DF. The biocompatibility of silver. Br Rev Biocompatibility 1989;5:221-243.
44. Hall RE, Bender G, Marquis RE. In vitro effects of ion intensity direct current generated silver on eukaryotic cells. J Oral Maxillofac Surg 1988;46:128-133.
45. Doherty PJ, Williams DF. The response of cells and cellular enzymes to silver. Presented at Biointeractions '87, Cambridge, UK, July 6-8, 1987.
46. Feng QL, Wu J, Chen GQ, Culi FZ, Kim TN, Kim JQ. A mechanistic study of the antibacterial effects of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000;52:662-668.
47. Wells TNC, Scully P, Paravicini G, Proudfoot AEI, Payton MA. Mechanism of irreversible inactivation of phosphomannose isomerase by silver ions and flamazine. Biochemistry 1995;34:7896-7903.